Common Infections — MCQs
On this page
A 71-year-old man with chronic kidney disease stage 4 (eGFR 22 mL/min/1.73m²) develops cellulitis of the left lower leg. He weighs 68kg and has no known drug allergies. The treating physician plans to prescribe oral flucloxacillin. According to antimicrobial stewardship principles and safe prescribing practices, which of the following represents the most appropriate approach?
A 45-year-old woman with well-controlled type 2 diabetes presents with a superficial surgical site infection following elective laparoscopic cholecystectomy 5 days ago. The wound shows mild erythema extending 2cm around the incision site with serous discharge but no purulence, fluctuance, or systemic features. Temperature is 37.3°C and inflammatory markers are mildly elevated (WCC 10.8 × 10⁹/L, CRP 35 mg/L). What is the most appropriate initial management?
A 62-year-old woman is admitted with severe community-acquired pneumonia and started on intravenous co-amoxiclav and clarithromycin. Blood and sputum cultures are sent on admission. At 72 hours, she has clinically improved with reduced oxygen requirements, and cultures remain negative. Temperature is 37.1°C, respiratory rate 16/min, oxygen saturation 96% on 2L/min oxygen. Which antimicrobial stewardship principle should guide the next management decision?
A hospital antimicrobial stewardship team is developing a policy for empirical antibiotic therapy. According to UK antimicrobial stewardship principles, which of the following timeframes represents the recommended maximum duration before antibiotic therapy should be reviewed and either stopped, switched to oral therapy, or continued based on clinical evidence?
A 58-year-old man with chronic venous insufficiency presents with a 4-day history of painful erythema of the right lower leg. The affected area is warm, tender, and has a sharply demarcated border extending from the ankle to mid-calf. Temperature is 38.2°C. He has no history of recent trauma or skin breaks. Blood tests show WCC 14.2 × 10⁹/L and CRP 85 mg/L. Which of the following is the most appropriate first-line antibiotic according to current UK guidelines?
Which of the following scenarios represents an appropriate indication for the use of topical antibiotics in primary care according to current UK antimicrobial prescribing guidance?
A 52-year-old man with liver cirrhosis (MELD score 18) presents with fever and right upper quadrant pain. Ultrasound shows a 6cm liver abscess. Blood cultures grow Klebsiella pneumoniae which is extended-spectrum beta-lactamase (ESBL) producing. The microbiology laboratory reports sensitivity to meropenem, gentamicin, and tigecycline, but resistance to all cephalosporins and co-amoxiclav. Which antibiotic represents the best choice according to antimicrobial stewardship principles?
A 43-year-old woman presents with a 2-day history of a painful red eye with purulent discharge. She wears soft contact lenses daily and continued wearing them despite developing symptoms. Visual acuity is reduced to 6/36 in the affected eye. Slit-lamp examination reveals a central corneal ulcer with surrounding infiltrate and hypopyon. What is the most important initial step in management?
A hospital trust analyses antimicrobial consumption data and identifies that carbapenem use has increased by 40% over 12 months despite no change in case mix or hospital admissions. Investigation reveals that 60% of carbapenem prescriptions are empirical therapy for suspected healthcare-associated infections. Which antimicrobial stewardship intervention would be most appropriate to address this?
A 59-year-old man with poorly controlled type 2 diabetes (HbA1c 92 mmol/mol) is admitted with a moderate diabetic foot ulcer (Wagner grade 2) with surrounding cellulitis extending 3cm beyond the ulcer margin. Temperature is 38.1°C. Plain radiograph shows no evidence of osteomyelitis. He has a documented severe penicillin allergy (anaphylaxis). According to current guidelines, what is the most appropriate empirical antibiotic regimen?
Common Infections UK Medical PG Practice Questions and MCQs
Question 181: A 71-year-old man with chronic kidney disease stage 4 (eGFR 22 mL/min/1.73m²) develops cellulitis of the left lower leg. He weighs 68kg and has no known drug allergies. The treating physician plans to prescribe oral flucloxacillin. According to antimicrobial stewardship principles and safe prescribing practices, which of the following represents the most appropriate approach?
- A. Prescribe standard dose flucloxacillin 1g four times daily without adjustment (Correct Answer)
- B. Reduce flucloxacillin dose to 250mg four times daily due to renal impairment
- C. Switch to oral doxycycline 200mg loading then 100mg daily due to renal safety profile
- D. Admit for intravenous vancomycin with therapeutic drug monitoring
- E. Prescribe oral clarithromycin 500mg twice daily to avoid renal complications
Explanation: ***Prescribe standard dose flucloxacillin 1g four times daily without adjustment***- Flucloxacillin is primarily cleared via the **hepatic** route, and therefore, **renal impairment** typically does not necessitate **dose adjustment**.- Maintaining the **standard dose** ensures optimal **therapeutic efficacy** against common cellulitis pathogens like **Staphylococcus aureus** and **Streptococcus pyogenes**, aligning with **antimicrobial stewardship** principles.*Reduce flucloxacillin dose to 250mg four times daily due to renal impairment*- Unnecessary dose reduction based on renal function for a hepatically metabolized drug would result in **subtherapeutic drug levels**.- This could lead to **treatment failure**, persistent infection, and potentially contribute to the development of **antimicrobial resistance**.*Switch to oral doxycycline 200mg loading then 100mg daily due to renal safety profile*- Although **doxycycline** is safe in renal impairment, it is not the first-line choice for typical cellulitis when an appropriate **narrow-spectrum penicillin** can be used.- Flucloxacillin is preferred for its targeted activity against the likely causative organisms of cellulitis, representing better **antimicrobial stewardship**.*Admit for intravenous vancomycin with therapeutic drug monitoring*- **Intravenous vancomycin** is generally reserved for severe infections, suspected **MRSA**, or patients unable to tolerate oral therapy, none of which are indicated here.- Uncomplicated cellulitis can often be safely and effectively managed with **oral antibiotics** in an outpatient setting, reducing hospitalizations.*Prescribe oral clarithromycin 500mg twice daily to avoid renal complications*- **Clarithromycin** is typically considered as an alternative for patients with a confirmed **penicillin allergy**, which is not present in this case.- Using a **macrolide** when a safe and effective **narrow-spectrum penicillin** is available is suboptimal for **antimicrobial stewardship** and can promote broader resistance.
Question 182: A 45-year-old woman with well-controlled type 2 diabetes presents with a superficial surgical site infection following elective laparoscopic cholecystectomy 5 days ago. The wound shows mild erythema extending 2cm around the incision site with serous discharge but no purulence, fluctuance, or systemic features. Temperature is 37.3°C and inflammatory markers are mildly elevated (WCC 10.8 × 10⁹/L, CRP 35 mg/L). What is the most appropriate initial management?
- A. Prescribe oral flucloxacillin 500mg four times daily for 7 days
- B. Arrange wound swab and commence oral co-amoxiclav pending results
- C. Open the wound, perform wound care, and review in 48 hours without antibiotics (Correct Answer)
- D. Admit for intravenous antibiotics due to diabetic status
- E. Prescribe topical fusidic acid cream twice daily for 5 days
Explanation: ***Open the wound, perform wound care, and review in 48 hours without antibiotics*** - For a **superficial surgical site infection (SSI)** showing only mild, localized erythema and serous discharge, *without* features like **purulence**, **fluctuance**, or **systemic illness** (normal temperature, mildly elevated inflammatory markers), local wound management is the appropriate first step. - This involves **opening the wound** to facilitate drainage of any accumulated fluid, followed by routine **wound care**. Antibiotics are typically not required unless there are clear signs of **spreading cellulitis** or systemic involvement. *Prescribe oral flucloxacillin 500mg four times daily for 7 days* - **Empirical oral antibiotics** are generally unwarranted for minor, superficial SSIs that do not exhibit significant bacterial invasion, such as extensive **cellulitis** (erythema >5cm), pus formation, or features of **systemic inflammatory response syndrome (SIRS)**. - Adhering to **antibiotic stewardship** guidelines, systemic antibiotics should be withheld for simple localized infections effectively managed by local measures, to prevent the emergence of **antibiotic resistance**. *Arrange wound swab and commence oral co-amoxiclav pending results* - **Wound swabs** from superficial infections often yield skin commensals and can lead to unnecessary antibiotic prescriptions; they are best reserved for severe, deep, or unresponsive infections, or when atypical pathogens are suspected. - **Co-amoxiclav** is a broad-spectrum antibiotic, which is inappropriate for a localized, superficial infection manageable with simple mechanical interventions, contributing to the development of **antimicrobial resistance**. *Admit for intravenous antibiotics due to diabetic status* - Admission for **intravenous antibiotics** is typically reserved for severe infections, deep-seated abscesses, or patients displaying significant **systemic compromise** or rapidly deteriorating clinical status, none of which are evident in this case. - Although diabetes is a risk factor for infections, the patient's condition is described as **well-controlled**, and the infection remains superficial without any signs of **sepsis** or widespread involvement, making inpatient IV antibiotics unnecessary. *Prescribe topical fusidic acid cream twice daily for 5 days* - **Topical antibiotics** have limited effectiveness in treating surgical site infections as they often lack sufficient penetration into the wound bed to eradicate deep-seated bacteria. - The widespread use of topical agents like **fusidic acid** is a significant driver of **antibiotic resistance**, particularly in common skin pathogens such as **Staphylococcus aureus**.
Question 183: A 62-year-old woman is admitted with severe community-acquired pneumonia and started on intravenous co-amoxiclav and clarithromycin. Blood and sputum cultures are sent on admission. At 72 hours, she has clinically improved with reduced oxygen requirements, and cultures remain negative. Temperature is 37.1°C, respiratory rate 16/min, oxygen saturation 96% on 2L/min oxygen. Which antimicrobial stewardship principle should guide the next management decision?
- A. Continue current IV antibiotics until day 7 to complete standard pneumonia course
- B. Switch to oral antibiotics and consider early discharge with community follow-up (Correct Answer)
- C. Stop all antibiotics immediately as cultures are negative
- D. Add intravenous levofloxacin for broader atypical coverage
- E. Continue IV antibiotics until all inflammatory markers normalize
Explanation: ***Switch to oral antibiotics and consider early discharge with community follow-up*** - This patient meets criteria for an **IV-to-oral switch (IVOS)**, as she is clinically stable, improving, and able to tolerate oral intake at the 72-hour review. - Transitioning to oral therapy reduces the risk of **cannula-associated infections**, lowers healthcare costs, and promotes earlier patient mobilization and **discharge**. *Continue current IV antibiotics until day 7 to complete standard pneumonia course* - Prolonged **intravenous therapy** after clinical stabilization increases the risk of **phlebitis** and hospital-acquired complications without providing additional clinical benefit. - Antimicrobial stewardship guidelines advocate for **early de-escalation** rather than adhering to a fixed IV duration when the patient is suitable for oral medication. *Stop all antibiotics immediately as cultures are negative* - A **negative culture** in community-acquired pneumonia does not rule out bacterial infection, as many causative organisms are difficult to grow or are suppressed by early antibiotic therapy. - Stopping treatment prematurely before completing a **standard course** (typically 5 days for moderate pneumonia) risks a clinical **relapse** or treatment failure. *Add intravenous levofloxacin for broader atypical coverage* - The patient is already showing significant **clinical improvement**, indicating that the current regimen of co-amoxiclav and clarithromycin is effectively treating the pathogens. - Adding a **fluoroquinolone** without clinical necessity represents inappropriate **antimicrobial escalation**, increasing the risk of side effects like C. difficile infection or antibiotic resistance. *Continue IV antibiotics until all inflammatory markers normalize* - Treatment decisions should be guided by **clinical stability** (temperature, heart rate, respiration) rather than waiting for laboratory **inflammatory markers** like CRP to fully normalize. - **CRP levels** often lag behind clinical improvement, and waiting for them to reach baseline would result in unnecessary, prolonged **intravenous antibiotic** exposure.
Question 184: A hospital antimicrobial stewardship team is developing a policy for empirical antibiotic therapy. According to UK antimicrobial stewardship principles, which of the following timeframes represents the recommended maximum duration before antibiotic therapy should be reviewed and either stopped, switched to oral therapy, or continued based on clinical evidence?
- A. 24 hours after initiation
- B. 48-72 hours after initiation (Correct Answer)
- C. 5 days after initiation
- D. 7 days after initiation
- E. When microbiology results become available
Explanation: ***48-72 hours after initiation*** - According to the **'Start Smart - Then Focus'** toolkit, all empirical antibiotic prescriptions must be formally reviewed between **48 to 72 hours**. - This timeframe allows for the integration of **microbiology results** and clinical response to decide on **IV-to-oral switch**, narrowing the spectrum, or stopping therapy. *24 hours after initiation* - Evaluating at **24 hours** is often too early to accurately judge **clinical improvement** or receive comprehensive culture sensitivities. - While monitoring is continuous, the **standardized review mandate** for policy development is specifically set later to capture diagnostic data. *5 days after initiation* - Waiting **5 days** increases the risk of **adverse effects**, such as Clostridioides difficile infection, if the therapy remains unnecessarily broad. - UK stewardship guidelines emphasize earlier intervention to promote **antimicrobial precision** and prevent resistance. *7 days after initiation* - **Seven days** is often the total duration of a complete course for many common infections, making it too late for a meaningful **clinical review**. - Relying on this window fails the **'Then Focus'** principle, which aims to optimize therapy as soon as evidence is available. *When microbiology results become available* - While culture results are vital, a review should happen within the **48-72 hour window** even if no organism is grown (**culture-negative** cases). - Clinical assessment of the patient's **hemodynamic stability** and symptoms is an independent trigger for review, regardless of lab timing.
Question 185: A 58-year-old man with chronic venous insufficiency presents with a 4-day history of painful erythema of the right lower leg. The affected area is warm, tender, and has a sharply demarcated border extending from the ankle to mid-calf. Temperature is 38.2°C. He has no history of recent trauma or skin breaks. Blood tests show WCC 14.2 × 10⁹/L and CRP 85 mg/L. Which of the following is the most appropriate first-line antibiotic according to current UK guidelines?
- A. Oral amoxicillin 500mg three times daily
- B. Oral flucloxacillin 500-1000mg four times daily (Correct Answer)
- C. Oral co-amoxiclav 625mg three times daily
- D. Oral clarithromycin 500mg twice daily
- E. Intravenous vancomycin 1g twice daily
Explanation: ***Oral flucloxacillin 500-1000mg four times daily*** - According to **NICE guidelines**, this is the first-line treatment for **cellulitis** and **erysipelas** as it provides excellent coverage against **Staphylococcus aureus** and **Group A Streptococcus**. - The patient presents with classic signs of soft tissue infection (erythema, warmth, tenderness) and systemic inflammatory response (**fever**, raised **WCC/CRP**) without signs of sepsis requiring IV therapy. *Oral amoxicillin 500mg three times daily* - **Amoxicillin** is ineffective against most strains of **Staphylococcus aureus** due to the production of **beta-lactamases**. - While it covers **Streptococcus**, it is not used as monotherapy for cellulitis because coverage for both common pathogens is essential. *Oral co-amoxiclav 625mg three times daily* - This is often reserved for **human/animal bites**, facial cellulitis, or infections with suspected **anaerobic** or **Gram-negative** involvement. - Using it for simple lower limb cellulitis contributes to **antimicrobial resistance** by providing unnecessarily broad-spectrum coverage. *Oral clarithromycin 500mg twice daily* - This is a **macrolide** antibiotic typically reserved for patients with a **penicillin allergy**. - Since there is no documentation of allergy in this patient, a **beta-lactam** like flucloxacillin is preferred for its superior efficacy in skin infections. *Intravenous vancomycin 1g twice daily* - This is reserved for severe infections, suspected **MRSA**, or patients who have failed oral therapy and require **intravenous** administration. - The patient's condition is currently manageable with **oral antibiotics**, and vancomycin requires intensive **serum level monitoring**.
Question 186: Which of the following scenarios represents an appropriate indication for the use of topical antibiotics in primary care according to current UK antimicrobial prescribing guidance?
- A. Acute bacterial conjunctivitis in an immunocompetent adult with purulent discharge and no visual impairment
- B. Impetigo affecting a limited area (<2% body surface area) in a 5-year-old child who is systemically well (Correct Answer)
- C. Small superficial abrasion on the forearm of a 30-year-old woman with no signs of infection
- D. Acute otitis externa in a 45-year-old man with marked canal oedema and purulent discharge
- E. Mild eczema with secondary bacterial infection in a 12-year-old child
Explanation: ***Impetigo affecting a limited area (<2% body surface area) in a 5-year-old child who is systemically well***- For **localized impetigo**, UK (NICE/PHE) antimicrobial stewardship guidelines recommend **topical fusidic acid** or **mupirocin** as first-line treatment if the patient is systemically well.- This approach avoids unnecessary **systemic antibiotic exposure** while effectively treating the infection and reducing transmission.*Acute bacterial conjunctivitis in an immunocompetent adult with purulent discharge and no visual impairment*- Most cases are **self-limiting**, and guidance recommends **conservative management** (cleaning the eye with cotton wool and water) rather than immediate topical antibiotics.- Topical antibiotics are usually only considered if symptoms are **severe** or persist beyond **7 days**.*Small superficial abrasion on the forearm of a 30-year-old woman with no signs of infection*- Prophylactic use of **topical antibiotics** on uninfected minor wounds is strongly discouraged to prevent **antimicrobial resistance**.- Routine cleaning and simple dressings are the standard of care for preventing infection in **clean abrasions**.*Acute otitis externa in a 45-year-old man with marked canal oedema and purulent discharge*- While topical drops are used, **marked canal oedema** may block the application of medication, necessitating an **ear wick** or **microsuction**.- Severe cases with significant swelling or systemic features may require **systemic antibiotics** as topical penetration is limited in a closed canal.*Mild eczema with secondary bacterial infection in a 12-year-old child*- Guidance typically recommends **oral (systemic) antibiotics** for secondary infections of eczema to ensure adequate coverage and efficacy across the affected skin areas.- Topical antibiotics are generally avoided in eczema due to the high risk of developing **bacterial resistance** and the potential for **contact sensitization**.
Question 187: A 52-year-old man with liver cirrhosis (MELD score 18) presents with fever and right upper quadrant pain. Ultrasound shows a 6cm liver abscess. Blood cultures grow Klebsiella pneumoniae which is extended-spectrum beta-lactamase (ESBL) producing. The microbiology laboratory reports sensitivity to meropenem, gentamicin, and tigecycline, but resistance to all cephalosporins and co-amoxiclav. Which antibiotic represents the best choice according to antimicrobial stewardship principles?
- A. Meropenem (Correct Answer)
- B. Gentamicin
- C. Tigecycline
- D. Combination of gentamicin and tigecycline
- E. Piperacillin-tazobactam based on susceptibility testing
Explanation: ***Meropenem*** - **Carbapenems** are the treatment of choice for invasive **ESBL-producing Enterobacterales** infections as they provide superior mortality outcomes compared to other agents. - Meropenem has excellent **abscess penetration** and stability against beta-lactamases, making it the most reliable option for this clinical scenario while adhering to stewardship principles by selecting the most effective agent for a severe, resistant infection. *Gentamicin* - This drug has poor efficacy in the **acidic environment** of an abscess and is generally unsuitable as **monotherapy** for systemic or deep-seated infections like a liver abscess. - There is a high risk of **nephrotoxicity** and ototoxicity, especially in a patient with cirrhosis and a high MELD score who may already have compromised renal perfusion, making it a less safe first-line option. *Tigecycline* - It is a **bacteriostatic** agent that achieves low serum concentrations, making it suboptimal for treating **bacteremia** or deep-seated invasive infections, especially as monotherapy. - Current guidelines recommend avoiding its use as primary therapy for serious infections when more effective and bactericidal alternatives like carbapenems are available due to concerns over higher mortality in severe infections. *Combination of gentamicin and tigecycline* - **Combination therapy** with these agents is not indicated here as meropenem monotherapy is highly effective and carries a lower risk of cumulative toxicity and poorer penetration into the abscess. - Using this combination increases the risk of adverse effects, such as **acute kidney injury** from gentamicin and overall concerns with tigecycline, without providing a proven clinical benefit over a single appropriate carbapenem. *Piperacillin-tazobactam based on susceptibility testing* - While some ESBL strains may appear sensitive to piperacillin-tazobactam in vitro, clinical outcomes are often poor for invasive infections due to the **inoculum effect** and instability against certain ESBL enzymes. - In this specific case, the lab reports **resistance to all cephalosporins and co-amoxiclav**, which are also beta-lactam/beta-lactamase inhibitor combinations or beta-lactams, making piperacillin-tazobactam a high-risk and likely clinically ineffective choice for an ESBL-producing Klebsiella pneumoniae.
Question 188: A 43-year-old woman presents with a 2-day history of a painful red eye with purulent discharge. She wears soft contact lenses daily and continued wearing them despite developing symptoms. Visual acuity is reduced to 6/36 in the affected eye. Slit-lamp examination reveals a central corneal ulcer with surrounding infiltrate and hypopyon. What is the most important initial step in management?
- A. Commence topical chloramphenicol immediately and arrange ophthalmology review within 24 hours
- B. Immediate ophthalmology referral, corneal scraping for microscopy and culture, and intensive topical fortified antibiotics (Correct Answer)
- C. Commence topical fusidic acid and arrange ophthalmology review within 48 hours
- D. Immediate ophthalmology referral and commence topical aciclovir for presumed herpetic keratitis
- E. Commence oral ciprofloxacin and topical dexamethasone with routine ophthalmology referral
Explanation: ***Immediate ophthalmology referral, corneal scraping for microscopy and culture, and intensive topical fortified antibiotics*** - The clinical presentation of a **painful red eye**, **purulent discharge**, significant **visual acuity reduction (6/36)**, **central corneal ulcer** with surrounding infiltrate, and **hypopyon** in a contact lens wearer strongly indicates severe **microbial keratitis**, a sight-threatening emergency. - **Immediate ophthalmology referral** for **corneal scraping** to identify the causative organism (often **Pseudomonas aeruginosa** or other Gram-negative bacteria in contact lens wearers) and initiation of **intensive topical fortified antibiotics** (e.g., fortified cephalosporin and aminoglycoside, or a broad-spectrum fluoroquinolone) are critical to prevent permanent vision loss. *Commence topical chloramphenicol immediately and arrange ophthalmology review within 24 hours* - **Chloramphenicol** is a broad-spectrum but bacteriostatic antibiotic typically used for milder conjunctivitis and is wholly inadequate for a severe, vision-threatening **corneal ulcer** with hypopyon. - A delay of **24 hours** for ophthalmology review in a case of presumed **microbial keratitis** with hypopyon is unacceptable and significantly increases the risk of severe complications like **corneal perforation** or endophthalmitis. *Commence topical fusidic acid and arrange ophthalmology review within 48 hours* - **Fusidic acid** has a narrow spectrum primarily effective against Gram-positive bacteria, particularly **Staphylococcus aureus**, and would not cover common pathogens like **Pseudomonas** often associated with contact lens-related keratitis. - Waiting **48 hours** for ophthalmology review in such a severe presentation of keratitis is dangerously prolonged and would lead to significant worsening of the condition. *Immediate ophthalmology referral and commence topical aciclovir for presumed herpetic keratitis* - While immediate ophthalmology referral is correct, the clinical features (purulent discharge, hypopyon, central ulcer) are highly suggestive of **bacterial keratitis**, not typical **herpetic keratitis**, which usually presents with a **dendritic ulcer** and less purulence. - Empiric use of **aciclovir** without confirmation of viral etiology would delay appropriate treatment for the likely bacterial infection, leading to progression and potential loss of vision. *Commence oral ciprofloxacin and topical dexamethasone with routine ophthalmology referral* - **Topical corticosteroids** like **dexamethasone** are absolutely **contraindicated** in undiagnosed infectious keratitis, as they can suppress the immune response, exacerbate the infection, and lead to rapid progression and **corneal perforation**. - Oral antibiotics have **poor corneal penetration** and are generally ineffective as primary treatment for severe keratitis, which requires high concentrations of **topical antibiotics** directly on the ocular surface; routine referral is also insufficient for an emergency.
Question 189: A hospital trust analyses antimicrobial consumption data and identifies that carbapenem use has increased by 40% over 12 months despite no change in case mix or hospital admissions. Investigation reveals that 60% of carbapenem prescriptions are empirical therapy for suspected healthcare-associated infections. Which antimicrobial stewardship intervention would be most appropriate to address this?
- A. Complete ban on carbapenem prescribing except with infectious diseases approval
- B. Implementing local antimicrobial resistance surveillance and antibiogram-guided empirical therapy guidance (Correct Answer)
- C. Reducing duration of all carbapenem courses to maximum 5 days
- D. Replacing carbapenems with alternative broad-spectrum agents such as piperacillin-tazobactam
- E. Mandatory screening for carbapenem-resistant organisms in all patients before carbapenem prescription
Explanation: ***Implementing local antimicrobial resistance surveillance and antibiogram-guided empirical therapy guidance***- This approach directly addresses the problem of increased empirical carbapenem use by providing **local epidemiological data** to guide appropriate **antibiotic selection**.- By utilizing **antibiograms**, clinicians can make informed decisions, opting for narrower-spectrum agents when possible and thereby reducing unnecessary carbapenem consumption and **antibiotic resistance**.*Complete ban on carbapenem prescribing except with infectious diseases approval*- A **complete ban** is an overly restrictive measure that can significantly delay critical treatment, especially in **unstable patients** with suspected severe infections.- While infectious diseases consultation is valuable, a blanket ban does not empower prescribers with the knowledge to make **data-driven decisions** and may lead to resistance to policy rather than adherence.*Reducing duration of all carbapenem courses to maximum 5 days*- This intervention focuses on the **duration of therapy** rather than the initial **empirical selection** of the antibiotic, which is the primary driver of increased carbapenem use identified.- An arbitrary **5-day limit** may be insufficient for certain severe or deep-seated infections, potentially leading to **treatment failure** or recurrence.*Replacing carbapenems with alternative broad-spectrum agents such as piperacillin-tazobactam*- Simply substituting one **broad-spectrum antibiotic** for another does not address the underlying issue of inappropriate empirical escalation and could merely shift the **resistance pressure** to the alternative agent.- Effective **antimicrobial stewardship** aims to optimize therapy by using the **narrowest effective spectrum** possible, not just rotating broad-spectrum drugs.*Mandatory screening for carbapenem-resistant organisms in all patients before carbapenem prescription*- While important for **infection control**, screening for **carbapenem-resistant organisms (CROs)** identifies colonization and is not typically used to guide immediate empirical therapy for acute infections due to **turnaround times**.- The primary issue is the high rate of empirical carbapenem use, not necessarily the presence of **known CROs** in the patient population.
Question 190: A 59-year-old man with poorly controlled type 2 diabetes (HbA1c 92 mmol/mol) is admitted with a moderate diabetic foot ulcer (Wagner grade 2) with surrounding cellulitis extending 3cm beyond the ulcer margin. Temperature is 38.1°C. Plain radiograph shows no evidence of osteomyelitis. He has a documented severe penicillin allergy (anaphylaxis). According to current guidelines, what is the most appropriate empirical antibiotic regimen?
- A. Oral doxycycline and oral metronidazole
- B. Intravenous teicoplanin and intravenous ciprofloxacin and intravenous metronidazole (Correct Answer)
- C. Intravenous clindamycin and intravenous gentamicin
- D. Oral clarithromycin and oral metronidazole
- E. Intravenous meropenem
Explanation: ***Intravenous teicoplanin and intravenous ciprofloxacin and intravenous metronidazole***- This combination provides broad-spectrum coverage against common pathogens in diabetic foot infections, targeting **Gram-positive** (teicoplanin), **Gram-negative** (ciprofloxacin), and **anaerobic** (metronidazole) bacteria, suitable for a moderate infection with systemic signs.- It is a crucial choice for patients with a **severe penicillin allergy (anaphylaxis)** as it completely avoids all beta-lactam antibiotics, minimizing the risk of cross-reactivity. *Oral doxycycline and oral metronidazole*- This **oral regimen** is generally insufficient for a **moderate diabetic foot infection** accompanied by fever (38.1°C) and cellulitis extending 3cm, indicating systemic involvement.- **Moderate to severe infections** typically necessitate **intravenous antibiotics** to achieve adequate drug concentrations and ensure effective tissue penetration in compromised diabetic feet. *Intravenous clindamycin and intravenous gentamicin*- While clindamycin provides some Gram-positive and anaerobic coverage, this regimen offers less comprehensive **anaerobic coverage** compared to metronidazole, which is vital in polymicrobial diabetic foot infections.- **Gentamicin** carries a significant risk of **nephrotoxicity** and ototoxicity, making it a less preferred option, especially in diabetic patients who are often prone to renal impairment. *Oral clarithromycin and oral metronidazole*- **Clarithromycin**, a macrolide, often lacks sufficient spectrum against the diverse aerobic Gram-negative and some Gram-positive pathogens commonly found in **diabetic foot infections**.- This **oral regimen** is inadequate for treating a **moderate infection** with systemic features that requires hospitalization and **parenteral antibiotic therapy** according to current guidelines. *Intravenous meropenem*- **Meropenem** is a carbapenem, a class of **beta-lactam antibiotics**, and thus carries a risk of cross-reactivity in patients with a history of **severe penicillin allergy (anaphylaxis)**.- Despite its broad spectrum, carbapenems are generally contraindicated in patients with documented **anaphylactic reactions to penicillin** to avoid potentially life-threatening allergic responses.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free